 SOUTH SAN FRANCISCO, Calif., Feb. 1, 2021 PRNewswire -- Titan Pharmaceuticals, Inc. NASDAQ: TTNP today announced that studies of its kappa opioid agonist peptide, JT-09, has demonstrated high potency and specificity for the human kappa-opioid receptor KOR. JT-09 is being developed... 